Product Dossier
FUNGILIN
Product Dossier for FUNGILIN (amphotericin B, Aspen Pharmacare). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Aspen Pharmacare
- Active ingredient: amphotericin B
- Therapeutic area: Infectious Disease
- Related brand: AMBISOME
- Same area: RETROVIR
- Same area: Savacol Antiseptic Mouth & Throat Rinse
What it is
FUNGILIN is amphotericin B in lozenge form, containing 10 mg per lozenge.
Approved indications
The source documents provided do not contain information about the approved therapeutic indications for FUNGILIN lozenges. The available product information describes AmBisome (liposomal amphotericin B injection), which is a different formulation and route of administration.
PBS listing
FUNGILIN 10 mg lozenge is listed on the PBS with an ex-manufacturer price of A$3.96, with unrestricted access.
Regulatory history
FUNGILIN amphotericin B 10 mg lozenge was first registered on the ARTG on 30 September 1991.